Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Wolters Kluwer
  6. Summary
    WKL   NL0000395903

WOLTERS KLUWER

(WKL)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Amsterdam
09/10/2021 09/13/2021 09/14/2021 09/15/2021 09/16/2021 Date
96.4(c) 96.18(c) 96.92(c) 95.72(c) 96.98 Last
349 953 280 919 356 455 551 056 437 085 Volume
-0.31% -0.23% +0.77% -1.24% +1.32% Change
More quotes
Estimated financial data (e)
Sales 2021 4 690 M 5 513 M 5 513 M
Net income 2021 710 M 834 M 834 M
Net Debt 2021 2 228 M 2 619 M 2 619 M
P/E ratio 2021 35,1x
Yield 2021 1,47%
Sales 2022 4 874 M 5 730 M 5 730 M
Net income 2022 764 M 898 M 898 M
Net Debt 2022 1 986 M 2 334 M 2 334 M
P/E ratio 2022 32,3x
Yield 2022 1,59%
Capitalization 24 863 M 29 383 M 29 228 M
EV / Sales 2021 5,78x
EV / Sales 2022 5,51x
Nbr of Employees 18 670
Free-Float 96,1%
More Financials
Company
Wolters Kluwer NV is a company based in the Netherlands that provides information, software and services to legal, business, tax, accounting, finance, audit, risk, compliance and healthcare professionals worldwide. The Company's four operating divisions are based on strategic customer segments: Health; Tax & Accounting; Governance, Risk & Compliance, and Legal & Regulatory. Its geographical segments include the... 
More about the company
Ratings of Wolters Kluwer
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about WOLTERS KLUWER
08:01aWOLTERS KLUWER : recognized with Gold Globee® in the 6th annual 2021 American Be..
BU
04:01aWOLTERS KLUWER : Share Buyback Transaction Details September 9 - September 15, 2..
AQ
09/14WOLTERS KLUWER : Legacy Health Selects Wolters Kluwer to Standardize Medication ..
BU
09/14Legacy Health Selects Wolters Kluwer N.V. to Standardize Medication Compoundi..
CI
09/13WOLTERS KLUWER : completes capital reduction
AQ
09/10WOLTERS KLUWER : N.V., - Wolters Kluwer Completes Capital Reduction
PU
09/10WOLTERS KLUWER : How are states tackling state tax deduction limit workarounds?
AQ
09/10WOLTERS KLUWER : Completes Capital Reduction
AQ
09/09WOLTERS KLUWER : N.V., - Share Buyback Transaction Details September 2 - Septemb..
PU
09/09WOLTERS KLUWER : MEDIA ALERT — How are states tackling state tax deduction..
BU
09/09WOLTERS KLUWER : TeamMate Live virtual conference to address agility in internal..
BU
09/09WOLTERS KLUWER : Share Buyback Transaction Details September 2 - September 8, 20..
AQ
09/08WOLTERS KLUWER : introduces Audit Data Analytics Resources to help CPA firms del..
BU
09/02WOLTERS KLUWER : We're Not Giving Away Your Shot – Wolters Kluwer Pharmaci..
BU
09/02WOLTERS KLUWER : Lippincott portfolio of journals sees sweeping impact factor ga..
AQ
More news
News in other languages on WOLTERS KLUWER
09/13BDO ITALIA : lancia 2* edizione del Master online Esg
09/10Wolters Kluwer trekt 5 miljoen aandelen in
09/09WOLTERS KLUWER : N.V. - Alphen aan den Rijn
09/09WOLTERS KLUWER : BlackRock, Inc. - Wolters Kluwer N.V. - Alphen aan den Rijn
09/09DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 09.09.2021 - 15.15 Uhr
More news
Analyst Recommendations on WOLTERS KLUWER
More recommendations
Chart WOLTERS KLUWER
Duration : Period :
Wolters Kluwer Technical Analysis Chart | WKL | NL0000395903 | MarketScreener
Technical analysis trends WOLTERS KLUWER
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Last Close Price 95,72 €
Average target price 86,56 €
Spread / Average Target -9,57%
EPS Revisions
Managers and Directors
Nancy McKinstry Chairman-Executive Board & Chief Executive Officer
Kevin B. Entricken Chief Financial Officer
Frans J. G. M. Cremers Chairman-Supervisory Board
Jeanette Horan Independent Member-Supervisory Board
Ann Elizabeth Ziegler Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
WOLTERS KLUWER38.60%29 383
S&P GLOBAL INC.37.54%108 914
THOMSON REUTERS CORPORATION44.21%58 908
RELX PLC20.84%57 805
MSCI INC.44.98%53 370
EQUIFAX INC.42.01%33 275